Neuroprotective strategies for the treatment of inherited photoreceptor degeneration

Current Molecular Medicine

Volumn 12, Issue 5, 2012, Pages 598-612

  Trifunovic D ^a   Sahaboglu, A ^a   Kaur, J ^a   Mencl, S ^a   Zrenner, E ^a   Ueffing, M ^a   Arango Gonzalez, B ^a   Paquet Durand, F ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Apoptosis; Calpain; Calpastatin; CGK; Epigenetics; HDAC; PARP; PKG

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GUANYLATE CYCLASE; NERVE GROWTH FACTOR; NEUROTROPHIN; PIGMENT EPITHELIUM DERIVED FACTOR; THIOCTIC ACID; XANTHOPHYLL; ZEAXANTHIN;

APOPTOSIS; CELL CULTURE; CELL DEATH; DEGENERATIVE DISEASE; EPIGENETICS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INHERITANCE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PHOTORECEPTOR; PHOTORECEPTOR CELL; PHOTORECEPTOR DEGENERATION; REGULATORY MECHANISM; RETINA DEGENERATION; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SIGNAL TRANSDUCTION; SURVIVAL; VALIDATION STUDY;

EID: 84861003107     PISSN: 15665240     EISSN: 18755666     Source Type: Journal    
DOI: 10.2174/156652412800620048     Document Type: Review

References (246)

1. Baehr W, Devlin MJ, Applebury ML. Isolation and characterization of cGMP phosphodiesterase from bovine rod outer segments. J Biol Chem 1979; 254: 11669-11677.
2. Palczewski K. G protein-coupled receptor rhodopsin. Annu Rev Biochem 2006; 75: 743-767.
3. Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet 2006; 368: 1795-1809.
4. Phelan JK, Bok D. A brief review of retinitis pigmentosa and the identified retinitis pigmentosa genes. Mol Vis 2000; 6:116-124.
5. Farrar GJ, Kenna PF, Humphries P. On the genetics of retinitis pigmentosa and on mutation-independent approaches to therapeutic intervention. EMBO J 2002; 21: 857-864.
6. Chang B, Hawes NL, Hurd RE, Davisson MT, Nusinowitz S, Heckenlively JR. Retinal degeneration mutants in the mouse. Vision Research 2002; 42: 517-525.
7. Dalke C, Graw J. Mouse mutants as models for congenital retinal disorders. Exp Eye Res 2005; 81: 503-512.
8. Bowes C, Li T, Danciger M, Baxter LC, Applebury ML, Farber DB. Retinal degeneration in the rd mouse is caused by a defect in the beta subunit of rod cGMP-phosphodiesterase. Nature 1990; 347: 677-680.
9. Portera-Cailliau C, Sung CH, Nathans J, Adler R. Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa. Proc Natl Acad Sci USA 1994; 91: 974-978.
10. Carter-Dawson LD, LaVail MM, Sidman RL. Differential effect of the rd mutation on rods and cones in the mouse retina. Invest Ophthalmol Vis Sci 1978; 17: 489-498.
11. Caffe AR, Soderpalm AK, Holmqvist I, van Veen T. A combination of CNTF and BDNF rescues rd photoreceptors but changes rod differentiation in the presence of RPE in retinal explants. Invest Ophthalmol Vis Sci 2000; 42: 275-282.
12. Miranda-Sanz M, Johnson LE, Ahuja S, Ekstrom PA, Romero J, van Veen T. Significant photoreceptor rescue by treatment with a combination of antioxidants in an animal model for retinal degeneration. Neuroscience 2007; 145: 1120-1129.
13. Zencak D, Crippa SV, Tekaya M, et al. BMI1 loss delays photoreceptor degeneration in Rd1 mice. Bmi1 loss and neuroprotection in Rd1 mice. Adv Exp Med Biol 2006; 572: 209-215.
14. Gorbatyuk MS, Knox T, LaVail MM, et al. Restoration of visual function in P23H rhodopsin transgenic rats by gene delivery of BiP/Grp78. Proc Natl Acad Sci USA 2010; 107: 5961-5966.
15. Maguire AM, Simonelli F, Pierce EA, et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med 2008; 358: 2240-2248.
16. Simonelli F, Maguire AM, Testa F, et al. Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration. Mol Ther 2010; 18: 643-650.
17. Bainbridge JW, Smith AJ, Barker SS, et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med 2008; 358: 2231-2239.
18. Cideciyan AV, Aleman TS, Boye SL, et al. Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics. Proc Natl Acad Sci USA 2008; 105: 15112-15117.
19. Akimoto M, Cheng H, Zhu D, et al. Targeting of GFP to newborn rods by Nrl promoter and temporal expression profiling of flow-sorted photoreceptors. Proc Natl Acad Sci USA 2006; 103: 3890-3895.
20. Chacko DM, Rogers JA, Turner JE, Ahmad I. Survival and differentiation of cultured retinal progenitors transplanted in the subretinal space of the rat. Biochem Biophys Res Commun 2000; 268: 842-846.
21. Wang NK, Tosi J, Kasanuki JM, et al. Transplantation of reprogrammed embryonic stem cells improves visual function in a mouse model for retinitis pigmentosa. Transplantation 2010; 89: 911-919.
22. MacLaren RE, Pearson RA, MacNeil A, et al. Retinal repair by transplantation of photoreceptor precursors. Nature 2006; 444: 203-207.
23. Lamba DA, Gust J, Reh TA. Transplantation of human embryonic stem cell-derived photoreceptors restores some visual function in Crx-deficient mice. Cell Stem Cell 2009; 4: 73-79.
24. Zrenner E. Will retinal implants restore vision? Science 2002; 295: 1022-1025.
25. Besch D, Sachs H, Szurman P, et al. Extraocular surgery for implantation of an active sub retinal visual prosthesis with external connections: feasibility and outcome in seven patients. Br J Ophthalmol 2008; 92: 1361-1368.
26. Zrenner E, Bartz-Schmidt KU, Benav H, et al. Subretinal electronic chips allow blind patients to read letters and combine them to words. Proc R Soc B 2011; 278: 1489-1497.
27. Ahuja AK, Dorn JD, Caspi A, et al. Blind subjects implanted with the Argus II retinal prosthesis are able to improve performance in a spatial-motor task. Br J Ophthalmol 2011; 95: 539-54
28. Lagali PS, Balya D, Awatramani GB, et al. Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration. Nat Neurosci 2008; 11: 667-675.
29. Lin B, Koizumi A, Tanaka N, Panda S, Masland RH. Restoration of visual function in retinal degeneration mice by ectopic expression of melanopsin. Proc Natl Acad Sci USA 2008; 105: 16009-160014.
30. Busskamp V, Duebel J, Balya D, et al. Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa. Science 2010; 329: 413-417
31. Busskamp V, Picaud S, Sahel JA, Roska B. Optogenetictherapy for retinitis pigmentosa. Gene Ther 2011 (Epub ahead of print).
32. Barkana Y, Belkin M. Neuro protection in ophthalmology: a review. Brain Res Bull 2004; 62: 447-453.
33. Chaum E. Retinal neuro protection by growth factors: a mechanistic perspective. J Cell Biochem 2003; 88: 57-75.
34. Komeima K, Rogers BS, Lu L, Campochiaro PA. Antioxidants reduce cone cell death in a model of retinitis pigmentosa. Proc Natl Acad Sci USA 2006; 103: 11300-11305.
35. Schatz A, Rock T, Naycheva L, et al. Transcorneal electrical stimulation for patients with retinitis pigmentosa: a prospective, randomized, sham-controlled exploratory study. Invest Ophthalmol Vis Sci 2011; 52: 4485-4496.
36. Chizzolini M, Galan A, Milan E, Sebastiani A, Costagliola C, Parmeggiani F. Good epidemiologic practice in retinitis pigmentosa: from phenotyping to biobanking. Curr Genomics 2011; 12: 260-266.
37. Chang GQ, Hao Y, Wong F. Apoptosis: final common pathway of photoreceptor death in rd, rds, and rhodopsin mutant mice. Neuron 1993; 11: 595-605.
38. Delyfer MN, Leveillard T, Mohand-Said S, Hicks D, Picaud S, Sahel JA. Inherited retinal degenerations: therapeutic prospects. Biol Cell 2004; 96: 261-269.
39. Kaur J, Mencl S, Sahaboglu A, et al. Calpain and PARP Activation during Photoreceptor Cell Death in P23H and S334ter Rhodopsin Mutant Rats. PLoS ONE 2011; 6: e22181.
40. Paquet-Durand F, Hauck SM, van Veen T, Ueffing M, Ekstrom P. PKG activity causes photoreceptor cell death in two retinitis pigmentosa models. J Neuro chem 2009; 108: 796-810.
41. Sancho-Pelluz J, Alavi M, Sahaboglu A, et al. Excessive HDAC activation is critical for neurodegeneration in the rd1 mouse. Cell Death & Disease 2010; 1(e24): 1-9.
42. Paquet-Durand F, Beck S, Michalakis S, et al. A key role for cyclic nucleotide gated (CNG) channels in cGMP-related retinitis pigmentosa. Hum Mol Genet 2011; 20: 941-947.
43. Trifunovic D, Dengler K, Michalakis S, Zrenner E, Wissinger B, Paquet-Durand F. GMP-dependent cone photoreceptordegeneration in the cpfl1 mouse retina. J Comp Neurol 2010; 518: 3604-3617.
44. Aloe L. Rita Levi-Montalcini: the discovery of nerve growthfactor and modern neurobiology. Trends Cell Biol 2004; 14: 395-399.
45. Bresnick GH. Oxygen-induced visual cell degeneration in the rabbit. Invest Ophthalmol 1970; 9: 372-387.
46. Emerich DF, Thanos CG. NT-501: an ophthalmic implant of polymer-encapsulated ciliary neurotrophic factor-producing cells. Curr Opin Mol Ther 2008; 10: 506-515.
47. Sieving PA, Caruso RC, Tao W, et al. Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants. Proc Natl Acad Sci USA 2006; 103: 3896-3901.
48. Kuno N, Fujii S. Biodegradable intraocular therapies for retinal disorders: progress to date. Drugs Aging 2010; 27: 117-134.
49. Cohen S, Levi-Montalcini R. A nerve growth-stimulating factor isolated from snake venom. Proc Natl Acad Sci USA 1956; 42: 571-574.
50. Cohen S, Levi-Montalcini R, Hamburger V. A nerve growth stimulating factor isolated from sarcom AS 37 and 180. Proc Natl Acad Sci USA 1954; 40: 1014-1018.
51. Cohen S. Purification of a nerve-growth promoting proteinfrom the mouse salivary gland and its neuro-cytotoxic antiserum. Proc Natl Acad Sci USA 1960; 46: 302-311.
52. Bocchini V, Angeletti PU. The nerve growth factor: purification as a 30,000-molecular-weight protein. Proc NatlAcad Sci USA 1969; 64: 787-794.
53. Lessmann V, Gottmann K, Malcangio M. Neurotrophin secretion: current facts and future prospects. Prog Neurobiol 2003; 69: 341-374.
54. Harada T, Harada C, Kohsaka S, et al. Micro glia-Muller glia cell interactions control neurotrophic factor production during light-induced retinal degeneration. J Neurosci 2002; 22: 9228-9236.
55. Wen R, Song Y, Cheng T, et al. Injury-induced upregulation of bFGF and CNTF mRNAS in the rat retina. J Neurosci 1995; 15: 7377-7385.
56. Yu DY, Cringle S, Valter K, Walsh N, Lee D, Stone J. Photoreceptor death, trophic factor expression, retinal oxygen status, and photoreceptor function in the P23H rat. Invest Ophthalmol Vis Sci 2004; 45: 2013-2019.
57. Hackam AS. Regulation of neurotrophin expression and activity in the retina. Adv Exp Med Biol 2008; 613: 343-349.
58. Boyd JG, Gordon T. Neuro trophic factors and their receptors in axonal regeneration and functional recovery after peripheral nerve injury. Mol Neurobiol 2003; 27: 277-324.
59. Deister C, Schmidt CE. Optimizing neurotrophic factor combinations for neurite outgrowth. J Neural Eng 2006; 3:172-179.
60. Barnstable CJ, Tombran-Tink J. Molecular mechanisms of neuroprotection in the eye. Adv Exp Med Biol 2006; 572: 291-295.
61. Cellerino A, Kohler K. Brain-derived neurotrophicfactor/neurotrophin-4 receptor TrkB is localized on ganglion cells and dopaminergic amacrine cells in the vertebrate retina. J Comp Neurol 1997; 386: 149-160.
62. Frade JM, Bovolenta P, Rodriguez-Tebar A. Neurotrophins and other growth factors in the generation of retinal neurons. Microsc Res Tech 1999; 45: 243-251.
63. Azadi S, Johnson LE, Paquet-Durand F, et al. CNTF+BDNFtreatment and neuroprotective pathways in the rd1 mouse retina. Brain Res 2007; 1129: 116-129.
64. Watanabe M, Sawai H, Fukuda Y. Survival of axoto mized retinal ganglion cells in adult mammals. Clin Neurosci 1997; 4: 233-239.
65. Cellerino A, Arango-Gonzalez BA, Kohler K. Effects of brainderivedneurotrophic factor on the development of NADPHdiaphorase/ nitric oxide synthase-positive amacrine cells in the rodent retina. Eur J Neurosci 1999; 11: 2824-2834.
66. Cellerino A, Arango-Gonzalez B, Pinzon-Duarte G, Kohler K. Brain-derived neurotrophic factor regulates expression of vasoactive intestinal polypeptide in retinal amacrine cells. J Comp Neurol 2003; 467:97-104.
67. Arango-Gonzalez B, Cellerino A, Kohler K. Exogenous brainderived neurotrophic factor (BDNF) reverts phenotypic changes in the retinas of transgenic mice lacking the BDNF gene. Invest Ophthalmol Vis Sci 2009; 50: 1416-1422.
68. Rickman DW. Parvalbumin immunoreactivity is enhanced bybrain-derived neurotrophic factor in organotypic cultures of rat retina. J Neurobiol 1999; 41: 376-384.
69. Pinzon-Duarte G, Arango-Gonzalez B, Guenther E, Kohler K. Effects of brain-derived neurotrophic factor on cell survival, differentiation and patterning of neuronal connections and Muller glia cells in the developing retina. Eur J Neurosci 2004; 19: 1475-1484.
70. LaVail MM, Yasumura D, Matthes MT, et al. Protection of mouse photoreceptors by survival factors in retinal degenerations. Invest Ophthalmol Vis Sci 1998; 39: 592-602.
71. Okoye G, Zimmer J, Sung J, et al. Increased expression of brain-derived neurotrophic factor preserves retinal function and slows cell death from rhodopsin mutation or oxidative damage. J Neurosci 2003; 23: 4164-4172.
72. Beltran WA, Zhang Q, Kijas JW, et al. Cloning, mapping, and retinal expression of the canine ciliary neurotrophic factor receptor alpha (CNTFRalpha). Invest Ophthalmol Vis Sci 2003; 44: 3642-3649.
73. Beltran WA, Rohrer H, Aguirre GD. Immunolocalization of ciliary neurotrophic factor receptor alpha (CNTFRalpha) in mammalian photoreceptor cells. Mol Vis 2005; 11: 232-244.
74. Liang FQ, Aleman TS, Dejneka NS, et al. Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa. Mol Ther 2001; 4: 461-472.
75. Tao W, Wen R, Goddard MB, et al. Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa. Invest Ophthalmol Vis Sci 2002; 43: 3292-3298.
76. LaVail MM. Survival factors for treatment of retinaldegenerative disorders: preclinical gains and issues for translation into clinical studies. Retina 2005; 25: S25-S26.
77. LaVail MM, Unoki K, Yasumura D, Matthes MT, Yancopoulos GD, Steinberg RH. Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light. Proc Natl Acad Sci USA 1992; 89: 11249-11253.
78. Bok D, Yasumura D, Matthes MT, et al. Effects of adenoassociated virus-vectored ciliary neurotrophic factor on retinal structure and function in mice with a P216L rds/peripherin mutation. Exp Eye Res 2002; 74: 719-735.
79. Xia X, Li Y, Huang D, et al. Oncostatin M protects rod and cone photoreceptors and promotes regeneration of cone outer segment in a rat model of retinal degeneration. PLoS ONE 2011; 6: e18282.
80. Rhee KD, Ruiz A, Duncan JL, et al. Molecular and cellular alterations induced by sustained expression of ciliary neurotrophic factor in a mouse model of retinitis pigmentosa. Invest Ophthalmol Vis Sci 2007; 48: 1389-400.
81. Schlichtenbrede FC, MacNeil A, Bainbridge JW, et al. Intraocular gene delivery of ciliary neurotrophic factor results in significant loss of retinal function in normal mice and in the Prph2Rd2/Rd2 model of retinal degeneration. Gene Ther 2003; 10: 523-52.
82. Kirsch M, Schulz-Key S, Wiese A, Fuhrmann S, Hofmann H. Ciliary neurotrophic factor blocks rod photoreceptor differentiation from postmitotic precursor cells in vitro. Cell Tissue Res 1998; 291: 207-216.
83. Schulz-Key S, Hofmann HD, Beisenherz-Huss C, Barbisch C, Kirsch M. Ciliary neurotrophic factor as a transientnegative regulator of rod development in rat retina. Invest Ophthalmol Vis Sci 2002; 43: 3099-3108.
84. Bok D. Ciliary neurotrophic factor therapy for inherited retinaldiseases: pros and cons. Retina 2005; 25: S27-S28.
85. Zhang Y, Kardaszewska AK, van VT, Rauch U, Perez MT. Integration between abutting retinas: role of glial structuresand associated molecules at the interface. Invest Ophthalmol Vis Sci 2004; 45: 4440-4449.
86. Talcott KE, Ratnam K, Sundquist SM, et al. Longitudinal study of cone photoreceptors during retinal degeneration and in response to ciliary neurotrophic factor treatment. Invest Ophthalmol Vis Sci 2011; 52: 2219-2226.
87. Tombran-Tink J, Shivaram SM, Chader GJ, Johnson LV, Bok D. Expression, secretion, and age-related downregulation of pigment epithelium-derived factor, a serpin with neurotrophic activity. J Neurosci 1995; 15: 4992-5003.
88. Perez-Mediavilla LA, Chew C, Campochiaro PA, et al. Sequence and expression analysis of bovine pigment epithelium-derived factor. Biochim Biophys Acta 1998; 1398: 203-214.
89. Wu YQ, Notario V, Chader GJ, Becerra SP. Identification of pigment epithelium-derived factor in the interphotoreceptor matrix of bovine eyes. Protein Expr Purif 1995; 6: 447-456.
90. Ogata N, Wada M, Otsuji T, Jo N, Tombran-Tink J, Matsumura M. Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 2002; 43: 1168-1175.
91. Behling KC, Surace EM, Bennett J. Pigment epitheliumderivedfactor expression in the developing mouse eye. Mol Vis 2002; 8: 449-454.
92. Karakousis PC, John SK, Behling KC, et al. Localization ofpigment epithelium derived factor (PEDF) in developing and adult human ocular tissues. Mol Vis 2001; 7: 154-163.
93. Ortego J, Escribano J, Becerra SP, Coca-Prados M. Gene expression of the neurotrophic pigment epithelium-derived factor in the human ciliary epithelium. Synthesis and secretion into the aqueous humor. Invest Ophthalmol Vis Sci 1996; 37: 2759-2767.
94. Bazan NG. Neuro trophins induce neuroprotective signaling in the retinal pigment epithelial cell by activating the synthesis of the anti-inflammatory and anti-apoptotic neuro protectin D1. Adv Exp Med Biol 2008; 613: 39-44.
95. Cao W, Tombran-Tink J, Elias R, Sezate S, Mrazek D, McGinnis JF. In vivo protection of photoreceptors from light damage by pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 2001; 42: 1646-1652.
96. Jablonski MM, Tombran-Tink J, Mrazek DA, Iannaccone A. Pigment epithelium-derived factor supports normal development of photoreceptor neurons and opsin expression after retinal pigment epithelium removal. J Neurosci 2000; 20: 7149-7157.
97. Nosrat CA, Tomac A, Lindqvist E, et al. Cellular expressionof GDNF mRNA suggests multiple functions inside andoutside the nervous system. Cell Tissue Res 1996; 286: 191-207.
98. Delyfer MN, Simonutti M, Neveux N, Leveillard T, Sahel JA. Does GDNF exert its neuroprotective effects on photoreceptors in the rd1 retina through the glial glutamate transporter GLAST? Mol Vis 2005; 11: 677-687.
99. Frasson M, Picaud S, Leveillard T, et al. Glial cell linederived neurotrophic factor induces histologic and functional protection of rod photoreceptors in the rd/rd mouse. Invest Ophthalmol Vis Sci 1999; 40: 2724-2734.
100. McGee Sanftner LH, Abel H, Hauswirth WW, Flannery JG. Glial cell line derived neuro trophic factor delays photoreceptor degeneration in a transgenic rat model of retinitis pigmentosa. Mol Ther 2001; 4: 622-629.
101. Lawrence JM, Keegan DJ, Muir EM, et al. Transplantation of Schwann cell line clones secreting GDNF or BDNF into the retinas of dystrophic Royal College of Surgeons rats. Invest Ophthalmol Vis Sci 2004; 45: 267-274.
102. Touchard E, Heiduschka P, Berdugo M, et al. Non-viral gene therapy for GDNF production in RCS rat: the crucial role of the plasmid dose. Gene Ther 2011 (Epub ahead of print).
103. Dalkara D, Byrne LC, Lee T, Hoffmann NV, Schaffer DV, Flannery JG. Enhanced gene delivery to the neonatal retina through systemic administration of tyrosine-mutated AAV9. Gene Ther 2011, 19: 176-181.
104. Hauck SM, Ueffing M. Muller-cell-derived neurotrophic factors, a road to neuroprotective therapy in the retina. Arch Soc Esp Oftalmol 2009; 84: 423-425.
105. Del Rio P, Irmler M, Arango-Gonzalez B, et al. GDNFinduced osteopontin from Muller glial cells promotes photoreceptor survival in the Pde6brd1 mouse model of retinal degeneration. Glia 2011; 59: 821-832.
106. Kent TL, Glybina IV, Abrams GW, Iezzi R. Chronicintravitreous infusion of ciliary neurotrophic factor modulates electrical retinal stimulation thresholds in the RCS rat. Invest Ophthalmol Vis Sci 2008; 49: 372-379.
107. Li Y, Tao W, Luo L, et al. CNTF induces regeneration of cone outer segments in a rat model of retinal degeneration. PLoS ONE 2010; 5: e9495.
108. Caffé AR, Ahuja P, Holmqvist B, et al. Mouse retina explants after long-term culture in serum free medium. J Chem Neuroanat 2001; 22: 263-273.
109. Ogilvie JM, Speck JD, Lett JM. Growth factors in combination, but not individually, rescue rd mouse photoreceptors in organ culture. Exp Neurol 2000; 161: 676-685.
110. Faktorovich EG, Steinberg RH, Yasumura D, Matthes MT, LaVail MM. Photoreceptor degeneration in inherited retinal dystrophy delayed by basic fibroblast growth factor. Nature 1990; 347: 83-86.
111. Faktorovich EG, Steinberg RH, Yasumura D, Matthes MT, LaVail MM. Basic fibroblast growth factor and local injury protect photoreceptors from light damage in the rat. J Neurosci 1992; 12: 3554-3567.
112. Cayouette M, Behn D, Sendtner M, Lachapelle P, Gravel C. Intraocular gene transfer of ciliary neurotrophic factor prevents death and increases responsiveness of rod photoreceptors in the retinal degeneration slow mouse. J Neurosci 1998; 18: 9282-9293.
113. Chong NH, Alexander RA, Waters L, Barnett KC, Bird AC, Luthert PJ. Repeated injections of a ciliary neurotrophicfactor analogue leading to long-term photoreceptor survivalin hereditary retinal degeneration. Invest Ophthalmol Vis Sci 1999; 40: 1298-1305.
114. Frasson M, Sahel JA, Fabre M, Simonutti M, Dreyfus H, Picaud S. Retinitis pigmentosa: rod photoreceptor rescue by a calcium-channel blocker in the rd mouse. Nat Med 1999; 5: 1183-1187.
115. von Bartheld CS. Neuro trophins in the developing and regenerating visual system. Histol Histopathol 1998; 13: 437-459.
116. Lenzi L, Coassin M, Lambiase A, Bonini S, Amendola T, Aloe L. Effect of exogenous administration of nerve growth factorin the retina of rats with inherited retinitis pigmentosa. Vision Res 2005; 45: 1491-1500.
117. Finkbeiner S, Tavazoie SF, Maloratsky A, Jacobs KM, Harris KM, Greenberg ME. CREB: a major mediator of neuronal neurotrophin responses. Neuron 1997; 19: 1031-1047.
118. Bonni A, Ginty DD, Dudek H, Greenberg ME. Serine 133- phosphorylated CREB induces transcription via a cooperative mechanism that may confer specificity to neurotrophin signals. Mol Cell Neurosci 1995; 6: 168-183.
119. Azadi S, Paquet-Durand F, Medstrand P, van Veen T, Ekstrom PA. Up-regulation and increased phosphorylation of protein kinase C (PKC) delta, mu and theta in the degenerating rd1 mouse retina. Mol Cell Neurosci 2006; 31:759-77
120. LaVail MM, Yasumura D, Matthes MT, et al. Ribozyme rescue of photoreceptor cells in P23H transgenic rats: longterm survival and late-stage therapy. Proc Natl Acad Sci USA 2000; 97: 11488-11493.
121. Hauswirth WW, LaVail MM, Flannery JG, Lewin AS. Ribozyme gene therapy for autosomal dominant retinal disease. Clin Chem Lab Med 2000; 38: 147-153.
122. Gregory-Evans K, Chang F, Hodges MD, Gregory-Evans CY. Ex vivo gene therapy using intravitreal injection of GDNFsecreting mouse embryonic stem cells in a rat model of retinal degeneration. Mol Vis 2009; 15: 962-973.
123. Mori K, Gehlbach P, Ando A, McVey D, Wei L, Campochiaro PA. Regression of ocular neovascularization in response toincreased expression of pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 2002; 43: 2428-2434.
124. Gardiner J, Barton D, Overall R, Marc J. Neuro trophic support and oxidative stress: converging effects in the normal and diseased nervous system. Neuroscientist 2009; 15: 47-61.
125. Yu DY, Cringle S, Valter K, Walsh N, Lee D, Stone J. Photoreceptor death, trophic factor expression, retinal oxygen status, and photoreceptor function in the P23H rat. Invest Ophthalmol Vis Sci 2004; 45: 2013-2019.
126. Kong L, Zhou X, Li F, Yodoi J, McGinnis J, Cao W. Neuroprotective effect of overexpression of thioredoxin on photoreceptor degeneration in Tubby mice. Neurobiol Dis 2010; 38: 446-455.
127. Bhatt L, Groeger G, McDermott K, Cotter TG. Rod and cone photoreceptor cells produce ROS in response to stress in a live retinal explant system. Mol Vis 2010; 16: 283-293.
128. St-Pierre J, Drori S, Uldry M, et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 2006; 127: 397-408.
129. Yu DY, Cringle SJ. Retinal degeneration and local oxygen metabolism. Exp Eye Res 2005; 80: 745-751.
130. Ahuja-Jensen P, Johnsen-Soriano S, Ahuja S, et al. Low glutathione peroxidase in rd1 mouse retina increases oxidative stress and proteases. Neuroreport 2007; 18: 797-801.
131. Franco R, Cidlowski JA. Apoptosis and glutathione: beyondan antioxidant. Cell Death Differ 2009; 16: 1303-1314.
132. Xu S, Touyz RM. Reactive oxygen species and vascular remodelling in hypertension: still alive. Can J Cardiol 2006; 22: 947-951.
133. Carmody RJ, McGowan AJ, Cotter TG. Reactive oxygenspecies as mediators of photoreceptor apoptosis in vitro. Exp Cell Res 1999; 248: 520-530.
134. Usui S, Komeima K, Lee SY, et al. Increased expression of catalase and superoxide dismutase 2 reduces cone cell death in retinitis pigmentosa. Mol Ther 2009; 17: 778-786.
135. Usui S, Oveson BC, Lee SY, et al. NADPH oxidase plays acentral role in cone cell death in retinitis pigmentosa. J Neurochem 2009; 110: 1028-1037.
136. Komeima K, Rogers BS, Campochiaro PA. Antioxidants slow photoreceptor cell death in mouse models of retinitis pigmentosa. J Cell Physiol 2007; 213: 809-815.
137. Tezel G. Oxidative stress in glaucomatousneurodegeneration: mechanisms and consequences. Prog Retin Eye Res 2006; 25: 490-513.
138. Thaler S, Fiedorowicz M, Grieb P, et al. Neuro protective effects of tempol acyl esters against retinal ganglion cell death in a rat partial optic nerve crush model. Acta Ophthalmol 2011; 89: e555-e560.
139. Paquet-Durand F, Silva J, Talukdar T, et al. Excessiveactivation of poly(ADP-ribose) polymerase contributes to inherited photoreceptor degeneration in the retinaldegeneration 1 mouse. J Neurosci 2007; 27: 10311-10319.
140. Krishnamoorthy RR, Crawford MJ, Chaturvedi MM, et al. Photo-oxidative stress down-modulates the activity of nuclear factor-kappaB via involvement of caspase-1, leading to apoptosis of photoreceptor cells. J Biol Chem 1999; 274: 3734-3743.
141. Rohrer B, Pinto FR, Hulse KE, Lohr HR, Zhang L, Almeida JS. Multi destructive pathways triggered in photoreceptor celldeath of the rd mouse as determined through gene expression profiling. J Biol Chem 2004; 279: 41903-41910.
142. Sanges D, Comitato A, Tammaro R, Marigo V. Apoptosis in retinal degeneration involves cross-talk between apoptosisinducing factor (AIF) and caspase-12 and is blocked by calpain inhibitors. Proc Natl Acad Sci USA 2006; 103: 17366-17371.
143. Doonan F, Donovan M, Cotter TG. Activation of multiple pathways during photoreceptor apoptosis in the rd mouse. Invest Ophthalmol Vis Sci 2005; 46: 3530-3538.
144. Berson EL. Retinitis pigmentosa. The Friedenwald Lecture. Invest Ophthalmol Vis Sci 1993; 34: 1659-1676.
145. Pasantes-Morales H, Quiroz H, Quesada O. Treatment with taurine, diltiazem, and vitamin E retards the progressive visual field reduction in retinitis pigmentosa: a 3-year followup study. Metab Brain Dis 2002; 17: 183-197.
146. Miranda M, Arnal E, Ahuja S, et al. Antioxidants rescue photoreceptors in rd1 mice: Relationship with thiol metabolism. Free Radic Biol Med 2010; 48: 216-222.
147. Ahuja P, Caffe AR, Ahuja S, Ekstrom P, van Veen T. Decreased glutathione transferase levels in rd1/rd1 mouse retina: replenishment protects photoreceptors in retinal explants. Neuroscience 2005; 131: 935-943.
148. Fridlich R, Delalande F, Jaillard C, et al. The thioredoxin-like protein rod-derived cone viability factor (RdCVFL) interacts with TAU and inhibits its phosphorylation in the retina. Mol Cell Proteomics 2009; 8: 1206-1218.
149. Cronin T, Raffelsberger W, Lee-Rivera I, et al. The disruption of the rod-derived cone viability gene leads to photoreceptor dysfunction and susceptibility to oxidative stress. Cell Death Differ 2010; 17: 1199-1210.
150. Baumgartner WA. Etiology, pathogenesis, and experimental treatment of retinitis pigmentosa. Med Hypotheses 2000; 54: 814-824.
151. Sibulesky L, Hayes KC, Pronczuk A, Weigel-DiFranco C, Rosner B, Berson EL. Safety of <7500 RE (<25000 IU) vitamin A daily in adults with retinitis pigmentosa. Am J Clin Nutr 1999; 69: 656-663.
152. Prasad PS, Schwartz SD, Hubschman JP. Age-related macular degeneration: current and novel therapies. Maturitas 2010; 66: 46-50.
153. Fiscus RR. Involvement of cyclic GMP and protein kinase G in the regulation of apoptosis and survival in neural cells. Neurosignals 2002; 11: 175-190.
154. Mendes HF, van der SJ, Chapple JP, Cheetham ME. Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy. Trends Mol Med 2005; 11: 177-185.
155. Michalakis S, Muhlfriedel R, Tanimoto N, et al. Restoration ofcone vision in the CNGA3(-/-) mouse model of congenital complete lack of cone photoreceptor function. Mol Ther 2010; 18: 2057-2063.
156. Ramamurthy V, Niemi GA, Reh TA, Hurley JB. Leber congenital amaurosis linked to AIPL1: a mouse model reveals destabilization of cGMP phosphodiesterase. ProcNatl Acad Sci USA 2004; 101: 13897-13902.
157. Karan S, Frederick JM, Baehr W. Involvement of guanylatecyclases in transport of photoreceptor peripheral membrane proteins. Adv Exp Med Biol 2008; 613: 351-359.
158. Nishiguchi KM, Sokal I, Yang L, et al. A novel mutation (I143NT) in guanylate cyclase-activating protein 1 (GCAP1)associated with auto somal dominant cone degeneration. Invest Ophthalmol Vis Sci 2004; 45: 3863-3870.
159. Olshevskaya EV, Ermilov AN, Dizhoor AM. Factors that affect regulation of cGMP synthesis in vertebrate photoreceptors and their genetic link to human retinal degeneration. Mol Cell Biochem 2002; 230: 139-147.
160. Semple-Rowland SL, Cheng KM. Chickens carry the same GC1 null allele (GUCY1*). Exp Eye Res 1999; 69: 575-581.
161. Tosi J, Davis RJ, Wang NK, Naumann M, Lin CS, Tsang SH. RNA knockdown of guanylate cyclase 2e or cyclic nucleotide gated channel alpha 1 increases photoreceptor survival in a cGMP phosphodiesterase mouse model of retinitis pigmentosa. J Cell Mol Med 2010; 15: 1778-1787.
162. Huttl S, Michalakis S, Seeliger M, et al. Impaired channel targeting and retinal degeneration in mice lacking the cyclic nucleotide-gated channel subunit CNGB1. J Neurosci 2005; 25: 130-138.
163. Hofmann F, Bernhard D, Lukowski R, Weinmeister P. GMP regulated protein kinases (cGK). Handb Exp Pharmacol 2009; 191: 137-162.
164. Koh JY, Cotman CW. Programmed cell death: its possible contribution to neurotoxicity mediated by calcium channel antagonists. Brain Res 1992; 587: 233-240.
165. Paquet-Durand F, Gierse A, Bicker G. Diltiazem protects human NT-2 neurons against excitotoxic damage in a model of simulated ischemia. Brain Res 2006; 1124: 45-54.
166. Podrygajlo G, Tegenge MA, Gierse A, et al. Cellular phenotypes of human model neurons (NT2) after differentiation in aggregate culture. Cell Tissue Res 2009; 336: 439-452.
167. Fox DA, Poblenz AT, He L. Calcium overload triggers rodphotoreceptor apoptotic cell death in chemical-induced and inherited retinal degenerations. Ann N Y Acad Sci 1999; 893: 282-285.
168. Vallazza-Deschamps G, Cia D, Gong J, et al. Excessive activation of cyclic nucleotide-gated channels contributes to neuronal degeneration of photoreceptors. Eur J Neurosci 2005; 22: 1013-1022.
169. Takeuchi K, Nakazawa M, Mizukoshi S. Systemic administration of nilvadipine delays photoreceptor degeneration of heterozygous retinal degeneration slow (rds)mouse. Exp Eye Res 2008; 86: 60-69.
170. Pearce-Kelling SE, Aleman TS, Nickle A, et al. Calcium channel blocker D-cis-diltiazem does not slow retinal degeneration in the PDE6B mutant rcd1 canine model of retinitis pigmentosa. Mol Vis 2001; 7: 42-47.
171. Pawlyk BS, Li T, Scimeca MS, Sandberg MA, Berson EL. Absence of photoreceptor rescue with D-cis-diltiazem in the rd mouse. Invest Ophthalmol Vis Sci 2002; 43: 1912-1915.
172. Takano Y, Ohguro H, Dezawa M, et al. Study of drug effects of calcium channel blockers on retinal degeneration of rd mouse. Biochem Biophys Res Commun 2004; 313: 1015-1022.
173. Lincoln TM, Cornwell TL. Intracellular cyclic GMP receptor proteins. FASEB J 1993; 7: 328-33
174. Deguchi A, Thompson WJ, Weinstein IB. Activation of protein kinase G is sufficient to induce apoptosis and inhibit cell migration in colon cancer cells. Cancer Res 2004; 64: 3966-3973.
175. Canzoniero LM, Adornetto A, Secondo A, et al. Involvement of the nitric oxide/protein kinase G pathway in polychlorinated biphenyl-induced cell death in SH-SY 5Y neuroblastoma cells. J Neurosci Res 2006; 84: 692-697.
176. Canals S, Casarejos MJ, de BS, Rodriguez-Martin E, Mena MA. Nitric oxide triggers the toxicity due to glutathione depletion in midbrain cultures through 12-lipoxygenase. J Biol Chem 2003; 278: 21542-21549.
177. Gonzalez-Forero D, Portillo F, Gomez L, Montero F, Kasparov S, Moreno-Lopez B. Inhibition of resting potassium conductances by long-term activation of the NO/cGMP/protein kinase G pathway: a new mechanism regulating neuronal excitability. J Neurosci 2007; 27: 6302-3612.
178. Castro LR, Schittl J, Fischmeister R. Feedback control through cGMP-dependent protein kinase contributes to differential regulation and compartmentation of cGMP in rat cardiac myocytes. Circ Res 2010; 107: 1232-1240.
179. Chang HY, Ready DF. Rescue of photoreceptor degeneration in rhodopsin-null Drosophila mutants by activated Rac1. Science 2000; 290: 1978-1980.
180. Haruta M, Bush RA, Kjellstrom S, et al. Depleting Rac1 in mouse rod photoreceptors protects them from photooxidative stress without affecting their structure or function. Proc Natl Acad Sci USA 2009; 106: 9397-9402.
181. Franco DL, Rezaval C, Caceres A, Schinder AF, Ceriani MF. ENA/VASP down regulation triggers cell death by impairing axonal maintenance in hippo campal neurons. Mol Cell Neurosci 2010; 44: 154-164.
182. Delcuve GP, Rastegar M, Davie JR. Epigenetic control. J Cell Physiol 2009; 219: 243-250.
183. Quenet D, El RR, Schreiber V, Dantzer F. The role ofpoly(ADP-ribosyl)ation in epigenetic events. Int J Biochem Cell Biol 2009; 41: 60-65.
184. Morrison BE, Majdzadeh N, D'Mello SR. Histone deacetylases: focus on the nervous system. Cell Mol Life Sci 2007; 64: 2258-2269.
185. Haberland M, Montgomery RL, Olson EN. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet 2009; 10: 32-42.
186. Schreiber V, Dantzer F, Ame JC, de MG. Poly(ADP-ribose): novel functions for an old molecule. Nat Rev Mol Cell Biol 2006; 7:517-528.
187. Pelzel HR, Schlamp CL, Nickells RW. Histone H4deacetylation plays a critical role in early gene silencing during neuronal apoptosis. BMC Neurosci 2010; 11: 62.
188. Chatoo W, Abdouh M, Duparc RH, Bernier G. Bmi1distinguishes immature retinal progenitor/stem cells from the main progenitor cell population and is required for normal retinal development. Stem Cells 2010; 28: 1412-1423.
189. Bommi PV, Dimri M, Sahasrabuddhe AA, Khandekar J, Dimri GP. The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitors. Cell Cycle 2010; 9: 2663-2673.
190. Chen B, Cepko CL. HDAC4 regulates neuronal survival in normal and diseased retinas. Science 2009; 323: 256-259.
191. Perillo B, Ombra MN, Bertoni A, et al. DNA oxidation astriggered by H3K9me2 demethylation drives estrogeninduced gene expression. Science 2008; 319: 202-206.
192. Metzger E, Wissmann M, Yin N, et al. LSD1 demethylates repressive histone marks to promote androgen-receptordependent transcription. Nature 2005; 437: 436-439.
193. Vakifahmetoglu H, Olsson M, Zhivotovsky B. Death through a tragedy: mitotic catastrophe. Cell Death Differ 2008; 15: 1153-1162.
194. Herrup K, Yang Y. Cell cycle regulation in the postmitoticneuron: oxymoron or new biology? Nat Rev Neurosci 2007; 8: 368-378.
195. Menu Dit HL, Lorentz O, Goureau O, Leveillard T, Sahel JA. DNA repair in the degenerating mouse retina. Mol Cell Neurosci 2004; 26: 441-449.
196. Jagtap P, Szabo C. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Discov 2005; 4: 421-440.
197. Skaper SD. Poly(ADP-Ribose) polymerase-1 in acuteneuronal death and inflammation: a strategy for neuroprotection. Ann N Y Acad Sci 2003; 993: 217-228.
198. Altmeyer M, Messner S, Hassa PO, Fey M, Hottiger MO. Molecular mechanism of poly(ADP-ribosyl)ation by PARP1 and identification of lysine residues as ADP-ribose acceptor sites. Nucleic Acids Res 2009; 37: 3723-3738.
199. Wang Y, Dawson VL, Dawson TM. Poly(ADP-ribose) signals to mitochondrial AIF: a key event in parthanatos. Exp Neurol 2009; 218:193-202.
200. Andrabi SA, Dawson TM, Dawson VL. Mitochondrial and nuclear cross talk in cell death: parthanatos. Ann N Y Acad Sci 2008; 1147: 233-241.
201. Sahaboglu A, Tanimoto N, Kaur J, et al. PARP1 gene knockout increases resistance to retinal degeneration without affecting retinal function. PLoS ONE 2010; 5: e15495.
202. Virag L, Szabo C. The therapeutic potential of poly(ADPribose) polymerase inhibitors. Pharmacol Rev 2002; 54: 375-429.
203. Goebel DJ, Winkler BS. Blockade of PARP activity attenuates poly(ADP-ribosyl)ation but offers only partial neuroprotection against NMDA-induced cell death in the rat retina. J Neurochem 2006; 98: 1732-1745.
204. Szabadfi K, Mester L, Reglodi D, et al. Novel neuroprotective strategies in ischemic retinal lesions. Int J Mol Sci 2010; 11: 544-561.
205. Uehara N, Miki K, Tsukamoto R, Matsuoka Y, Tsubura A. Nicotinamide blocks N-methyl-N-nitrosourea-induced photoreceptor cell apoptosis in rats through poly (ADPribose) polymerase activity and Jun N-terminal kinase/activator protein-1 pathway inhibition. Exp Eye Res 2006; 82: 488-495.
206. Sharma AK, Rohrer B. Calcium-induced calpain mediates apoptosis via caspase-3 in a mouse photoreceptor cell line. J Biol Chem 2004; 279: 35564-35572.
207. Zeiss CJ, Neal J, Johnson EA. Caspase-3 in postnatal retinal development and degeneration. Invest Ophthalmol Vis Sci 2004; 45: 964-970.
208. Doonan F, Donovan M, Cotter TG. Caspase-independentphotoreceptor apoptosis in mouse models of retinal degeneration. J Neurosci 2003; 23: 5723-5731.
209. Sancho-Pelluz J, Arango-Gonzalez B, Kustermann S, Romero et al. Photoreceptor cell death mechanisms in inherited retinal degeneration. Mol Neurobiol 2008; 38: 253-269.
210. Paquet-Durand F, Johnson L, Ekstrom P. Calpain activity inretinal degeneration. J Neurosci Res 2007; 85: 693-702.
211. Ahuja S, Ahuja-Jensen P, Johnson LE, et al. Rd1 Mouse retina shows an imbalance in the activity of cysteine protease cathepsins and their endogenous inhibitor cystatin C. Invest Ophthalmol Vis Sci 2008; 49: 1089-1096.
212. Goll DE, Thompson VF, Li H, Wei W, Cong J. The calpain system. Physiol Rev 2003; 83: 731-801.
213. Hood JL, Brooks WH, Roszman TL. Differential compartmentalization of the calpain/calpastatin network with the endoplasmic reticulum and Golgi apparatus. J Biol Chem 2004; 279: 43126-43135.
214. Suzuki S, Humayun MS, Weiland JD, et al. Comparison ofelectrical stimulation thresholds in normal and retinal degenerated mouse retina. Jpn J Ophthalmol 2004; 48: 345-349.
215. Azuma M, Shearer TR. The role of calcium-activated protease calpain in experimental retinal pathology. Surv Ophthalmol 2008; 53: 150-163.
216. Suzuki K, Hata S, Kawabata Y, Sorimachi H. Structure, activation, and biology of calpain. Diabetes 2004; 53: S12-S18.
217. Rao MV, Mohan PS, Peterhoff CM, et al. Marked calpastatin (CAST) depletion in Alzheimer's disease accelerates cytoskeleton disruption and neurodegeneration:neuroprotection by CAST overexpression. J Neurosci 2008;28: 12241-1225
218. Oka S, Ohno M, Tsuchimoto D, Sakumi K, Furuichi M, Nakabeppu Y. Two distinct pathways of cell death triggered by oxidative damage to nuclear and mitochondrial DNAs. EMBO J 2008; 27: 421-432.
219. Vosler PS, Brennan CS, Chen J. Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration. Mol Neurobiol 2008; 38: 78-100.
220. Liu X, Van VT, Schnellmann RG. The role of calpain in oncotic cell death. Annu Rev Pharmacol Toxicol 2004; 44:349-370.
221. Camins A, Verdaguer E, Folch J, Pallas M. Involvement of calpain activation in neurodegenerative processes. CNS Drug Rev 2006; 12: 135-148.
222. Wingrave JM, Sribnick EA, Wilford GG, et al. Higher calpastatin levels correlate with resistance to calpainmediated proteolysis and neuronal apoptosis in juvenile rats after spinal cord injury. J Neurotrauma 2004; 21: 1240-1254.
223. Higuchi M, Tomioka M, Takano J, et al. Distinct mechanisticroles of calpain and caspase activation in neurodegeneration as revealed in mice overexpressing their specific inhibitors. J Biol Chem 2005; 280: 15229-1527.
224. Paquet-Durand F, Azadi S, Hauck SM, Ueffing M, van Veen T, Ekstrom P. Calpain is activated in degenerating photoreceptors in the rd1 mouse. J Neurochem 2006; 96: 802-814.
225. Gomez-Vicente V, Donovan M, Cotter TG. Multiple death pathways in retina-derived 661W cells following growth factor deprivation: crosstalk between caspases and calpains. Cell Death Differ 2005; 12: 796-804.
226. Araujo CL, Sampaio NM, Hokoc JN, Blanco Martinez AM. Calpain inhibitor 2 prevents axonal degeneration of opossum optic nerve fibers. J Neurosci Res 2004; 77: 410-419.
227. Das A, Garner DP, Del Re AM, et al. Calpeptin provides functional neuroprotection to rat retinal ganglion cells following Ca2+ influx. Brain Res 2006; 1084: 146-157.
228. Oka T, Tamada Y, Nakajima E, Shearer TR, Azuma M. Presence of calpain-induced proteolysis in retinal degeneration and dysfunction in a rat model of acute ocular hypertension. J Neurosci Res 2006; 83: 1342-1351.
229. Donkor IO. A survey of calpain inhibitors. Curr Med Chem 2000; 7: 1171-11788.
230. Fukiage C, Azuma M, Nakamura Y, Tamada Y, Shearer TR.Calpain-induced light scattering by crystallins from three rodent species. Exp Eye Res 1997; 65: 757-770.
231. Ravid T, Doolman R, Avner R, Harats D, Roitelman J. Theubiquitin-proteasome pathway mediates the regulated degradation of mammalian 3-hydroxy-3-methylglutarylcoenzyme A reductase. J Biol Chem 2000; 275: 35840-35847.
232. Maki M, Bagci H, Hamaguchi K, Ueda M, Murachi T, Hatanaka M. Inhibition of calpain by a synthetic oligopeptide corresponding to an exon of the human calpastatin gene. J Biol Chem 1989; 264: 18866-18869.
233. Uemori T, Shimojo T, Asada K, et al. Characterization of a functional domain of human calpastatin. Biochem Biophys Res Commun 1990; 166: 1485-1493.
234. Sharma AK, Rohrer B. Sustained elevation of intracellular cGMP causes oxidative stress triggering calpain-mediated apoptosis in photoreceptor degeneration. Curr Eye Res 2007; 32: 259-269.
235. Paquet-Durand F, Sanges D, McCall J, et al. Photoreceptor rescue and toxicity induced by different calpain inhibitors. J Neurochem 2010; 115: 930-940.
236. Arthur JS, Elce JS, Hegadorn C, Williams K, Greer PA. Disruption of the murine calpain small subunit gene, Capn4: calpain is essential for embryonic development but not for cell growth and division. Mol Cell Biol 2000; 20: 4474-4481.
237. Tan Y, Wu C, De VT, Greer PA. Ubiquitous calpains promoteboth apoptosis and survival signals in response to different cell death stimuli. J Biol Chem 2006; 281: 17689-17698.
238. Marcum JL, Mathenia JK, Chan R, Guttmann RP. Oxidation of thiol-proteases in the hippocampus of Alzheimer's disease. Biochem Biophys Res Commun 2005; 334:342-348.
239. Berger W, Kloeckener-Gruissem B, Neidhardt J. Themolecular basis of human retinal and vitreoretinal diseases. Prog Retin Eye Res 2010; 29: 335-375.
240. Euler T, Hausselt SE, Margolis DJ, et al. Eyecup scope-- optical recordings of light stimulus-evoked fluorescence signals in the retina. Pflugers Arch 2009; 457: 1393-1414.
241. Cordeiro MF, Guo L, Coxon KM, et al. Imaging multiple phases of neurodegeneration: a novel approach to assessing cell death in vivo. Cell Death Dis 2010; 1: e3.
242. Apweiler R, Aslanidis C, Deufel T, et al. Approaching clinicalproteomics: current state and future fields of application in cellular proteomics. Cytometry A 2009; 75: 816-832.
243. Nomura DK, Dix MM, Cravatt BF. Activity-based protein profiling for biochemical pathway discovery in cancer. Nat Rev Cancer 2010; 10: 630-638.
244. Cazares LH, Troyer DA, Wang B, Drake RR, John SO.MALDI tissue imaging: from biomarker discovery to clinical applications. Anal Bioanal Chem 2011; 401: 17-27.
245. Lohr HR, Kuntchithapautham K, Sharma AK, Rohrer B. Multiple, parallel cellular suicide mechanisms participate in photoreceptor cell death. Exp Eye Res 2006; 83: 380-389.
246. Schlatter R, Schmich K, Avalos V, et al. ON/OFF and beyond--a boolean model of apoptosis. PLoS Comput Biol 2009; 5: e1000595